18.34 USD
▼-0.64-3.37%
盘后 18.58 0.00%
2026-11-19
市值
$813.08M
市盈率
—
EPS
-7.96
股息率
—
52 周区间
15.10 – 29.05
成交量
419.24K
Beta
—
目标价
34.67
52W 低 15.1052W 高 29.05
价格走势
公司简介
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic inflammatory responses activation of interferon regulatory factor 5 (IRF5); OD-003, a protein therapeutic designed to agonize tumor necrosis...